Clinical trial
Effects of "ShengXian-QuYu Decoction" on Quality of Life, Symptoms, and Biomarkers in Heart Failure Patients With Reduced and Mildly Reduced Ejection Fraction: a Pragmatic, Nationwide, Multicenter, Parallel Group, Randomized, Double-Blind, Placebo-Controlled Trial
NCT05583773 is registered in ClinicalTrials.gov with China-Japan Friendship Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of "ShengXian-QuYu Decoction" on Quality of Life, Symptoms, and Biomarkers in Heart Failure Patients With Reduced and Mildly Reduced Ejection Fraction: a Pragmatic, Nationwide, Multicenter, Parallel Group, Randomized, Double-Blind, Placebo-Controlled Trial
- Lead sponsor
- China-Japan Friendship Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 29, 2023
- Completion date
- December 31, 2025
- Enrollment
- 336 (estimated)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.